|
| Upcoming Events week of April 10- April 16 |
|
|
April 12
|
CCB Spring Seminar Series – 12-1P, HSN Room 2157
Andrew Kossenkov, PhD
Director, Bioinformatics Facility
Center for Systems & Computational Biology
The Wistar Institute
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level |
April 28-30
|
The WVU Cancer Institute’s 32nd Annual Spring Gala is just around the corner. Have you registered yet?
To register and view the schedule of events
|
|
|
|
Are you unable to undergo an invasive procedure? Home tests are available for colon cancer screening
A colonoscopy is the gold standard for early detection of colon cancer. But what if you can't undergo an invasive procedure? Take-home sample tests are available, with a range of effectiveness.
Learn more from this WVU Medicine Health Report
Hannah Hazard and Geraldine Jacobson featured in WVU Magazine article |
 |
|
|
| Hannah Hazard, MD |
Geraldine Jacobson, MD, MPH, MBA |
Dr. Hannah Hazard, director of Clinical Services and surgeon-in-chief at WVU and Dr. Geraldine Jacobson, radiation oncologist, professor and chair of the WVU Department of Radiation Oncology, are featured in a WVU Magazine along with Dr. Paul Lockman’s research on breast cancer metastasis to the brain. In the article titled “In the Path of Cancer,” the Spring 2017 issue of the publication, Hazard and Jacobson share their expertise on breast cancer metastases and the methods and tools used at WVU to effectively treat the disease.
Read more
|
|
Login to The Cancer Letter and The Clinical Cancer Letter through WVU’s network
You can now login to The Cancer Letter and The Clinical Cancer Letter through WVU’s institutional subscription. The Cancer Letter, an independent weekly newsletter, is the leading source of information on development of cancer therapies, cancer research funding, legislation and more. The Clinical Cancer Letter is a monthly newsletter that provides an at-a-glance update on clinical developments. Login instructions:
1. Go to www.cancerletter.com
2. Click IP Login on the navigation bar. You will be taken directly to the latest issue. There is no need to enter any other login information.
3. If you would like to be notified when new issues of The Cancer Letter and The Clinical Cancer Letter are available, click Join our Mailing List and enter your contact information. Issues of The Cancer Letter are published every Friday.
3. If you would like to be notified when new issues of The Cancer Letter and The Clinical Cancer Letter are available, click Join The Cancer Letter Mailing List and enter your contact information. Issues of The Cancer Letter are published every Friday.
If you have any trouble logging in, please contact paul@cancerletter.com with the IP address returned to you in the error message.
If you have questions or technical assistance, contact Angela Spring at angela@cancerletter or (202) 595-2070, ext. 103.
Cancer Institute seeks teams for Relay For Life
Please consider joining your colleagues in WVU Medicine and the WVU Cancer Institute in forming or joining a team for the 2017 American Cancer Society Monongalia County Relay For Life on June 9 at Westwood Middle School track and field in Morgantown. Our Cancer Institute is the presenting sponsor and we currently have 17 teams formed.
There are three ways to join:
1) Join CANCER CRUSHERS (already formed team) on the Relay For Life site below-
2) Join the event: Form your own team - Place Cursor on site above, select the Mon County Event not the WVU event and follow the registration instructions.
3) Complete the Registration Forms available in Donna Tamasco’s or Annorah Cale’s office and return it to the Cancer Clinic/BMT mail box in Annorah’s office.
Please contact the Cancer Institute’s Dave Staten, team ambassador for this year’s Mon. Co. Relay, with any questions, or call him at 304-598-4500 ext 74520.
Give back through Gold Blue and You
The Gold Blue and You Faculty & Staff Campus Campaign is in full swing. This annual fundraising effort provides WVU faculty and staff and WVU Medicine employees an opportunity to directly impact the WVU community through their charitable donations. For more details, please pick up a brochure from one of the posters located in the atrium and the first floor lobby area of the Cancer Institute.
To donate online
West Virginia Black Bears 2017 season tickets are on sale now
WVU Medicine is a team sponsor. Employees will receive $25 in Black Bear Bucks for each season ticket purchased.
Read more
CP&C's Amy Allen attends the Georgetown University School of Business New Strategies Forum
|
 |
|
Cancer Prevention and Control’s Amy Allen recently participated in an advanced leadership education program exclusively designed to help nonprofit executives generate added financial support. The “New Strategies” Program is open to nonprofit executives sponsored by corporations or foundations that provide grants to cover all program expenses, including the Forum held on the Georgetown campus. Amy’s participation was sponsored by Bristol-Meyers Squibb Foundation in support of Cancer Prevention and Control’s work to address cancer health disparities.
Read more |
|
Learn about the latest actions and activities of the West Virginia Legislature in Under the Dome. April 3 update
Join 800 Club and help Coach Huggins defeat cancer
Get behind a winning coach in the fight against cancer in West Virginia. Sign up now to join the Bob Huggins 800 Club. Help celebrate and commemorate Coach’s extraordinary head coaching career and benefit the Norma Mae Huggins Cancer Research Endowment Fund at the WVU Cancer Institute.
Read more
School of Public Health faculty, student publish e-cigarette research
Drs. Alfgeir Kristjansson and Mike Mann, along with PhD candidate Shay Daily, have research featured in the June 2017 issue of Public Health, an international, peer-reviewed journal.
Read more
David Klinke to be inducted into national engineering honorary
Congratulations to David Klinke, PhD, for being selected as an inductee into Tau Beta Pi, the engineering honorary. Dr. Klinke, a member of the WVU Cancer Institute Mechanisms of Metastasis & Therapeutic Response Program, is an adjunct associate professor in the WVU Department of Microbiology, Immunology & Cell Biology. He recently received a $1.7 million grant from the National Cancer Institute to conduct research into how immunotherapy can strengthen the body’s own defenses to improve treatment for breast and lung cancers.
Read more
“Unmask Cancer” Ball, part of activities at the WVU Cancer Institute’s 32nd Annual Spring Gala
Come be a part of an event that saves lives! Register now for the WVU Cancer Institute 32nd Annual Spring Gala at The Greenbrier Resort in White Sulphur Springs, West Virginia, April 28-30. Among the wide variety of activities and entertainment on tap during the weekend-long signature event is the “Unmask Cancer” Black-Tie Masquerade Ball.
Read more
|
|
|
|
|
|
|
|
|
|
|
|
Co-activation of STAT3 and YES-associated protein 1 (YAP1) pathway in EGFR-mutant NSCLC.
Chaib I, Karachaliou N, Pilotto S, Codony Servat J, Cai X, Li X, Drozdowskyj A, Servat CC, Yang J, Hu C, Cardona AF, Vivanco GL, Vergnenegre A, Sanchez JM, Provencio M, Reguart N, Zhou C, Cao P, Ma PC, Bivona TG, Rosell R.
J Natl Cancer Inst. 2017;109(9).
Read More
Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?
Kharfan-Dabaja MA, El-Jurdi N, Ayala E, Kanate AS, Savani BN, Hamadani M.
Bone Marrow Transplant. 2017.
Read More |
|
|
|
|
Federal Grants and Opportunities
Health Information Technology (IT) to Improve Health Care Quality and Outcomes (R21) - PA-17-246
Organization: AHRQ
Summary: This FOA issued by AHRQ invites grant applications for funding to conduct exploratory and developmental research grants (R21) for projects in the early and conceptual stages of development that will contribute to the evidence base of how health information technology (IT) improves health care quality and outcomes.
Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18) - PA-17-247
Organization: AHRQ
Summary: This Funding Opportunity Announcement (FOA) invites U18 cooperative agreement applications to stimulate innovative and collaborative research by utilizing new health information technology (IT) strategies for collecting and using patient-reported outcome (PRO) measures in primary care and other ambulatory care settings.
Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) - PAR-17-244
Organization: NCI
Summary: The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for collaborative R01 projects from multi-disciplinary teams to expand, improve, or transform the reliability and utility of mammalian cancer and tumor models for translational research. For a linked set of collaborative R01s, each site has its own Program Director(s)/Principal Investigator(s), and the program provides a mechanism for cross-site coordination and communication. Collaborative studies are appropriate to address translational modeling research questions beyond the capacity of a single-site investigation, particularly to accommodate collaborations among sites with diverse expertise, perspectives, and contributions.
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) - PAR-17-245
Organization: NCI
Summary: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research.
Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp) - PA-17-248
Organization: NCI
Summary: The overarching goal of this Funding Opportunity Announcement (FOA) is to support collaborative pilot projects to generate new ideas and approaches to reduce the incidence and/or severity of auto-inflammatory or autoimmune adverse events in the setting of cancer immunotherapy. In order to facilitate formation of multidisciplinary teams with expertise in mechanisms of cancer immunology/immunotherapy as well as immune tolerance and/or autoimmunity, teams that include (a) a current NCI grantee and a current NIAID grantee, or (b) a current NCI grantee and a current NIAMS grantee, are encouraged to propose collaborative pilot projects that utilize their complementary and synergistic expertise.
Resource Centers for Minority Aging (RCMAR) Coordinating Center (R24) - RFA-AG-18-004
Organization: NIA
Summary: This FOA invites applications from qualified institutions to create or continue Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (CC). The RCMAR Program aims to enhance the diversity of the aging research workforce by mentoring promising scientists from under-represented groups for sustained careers in aging research. RCMARs focus on priority areas of social, behavioral, and economic research on the processes of aging at the individual or societal level. The program supports research at multiple levels from genetics to cross-national comparative research, and at stages from basic through translational, with the goal to improve the health, well-being, function, and independence of older Americans. The new cycle of RCMARs will expand the scientific scope of the program to encourage transdisciplinary social and behavioral science research on any theme addressed in the National Institute on Aging Strategic Plan, and will include a new cohort of RCMARs focused on behavioral and social science related to Alzheimer's disease and related dementias (ADRD). Consistent with the longstanding focus of the RCMAR program on minority aging research, all centers are also expected to offer mentoring in health disparities and minority aging issues as a major component of their investigator development programs, thereby enhancing the potential impact of research supported by the program on all sectors of our aging society. The RCMAR CC will facilitate and coordinate trans-RCMAR activities. The CC will work closely with the NIA Program Officer and, in coordination with all RCMAR sites, be responsive to requests generated by key RCMAR site personnel, NIA, NIH, the scientific community, and the general public.
Resource Centers for Minority Aging Research (P30) - RFA-AG-18-003
Organization: NIA
Summary: The National Institute on Aging (NIA) invites applications from qualified institutions for the creation or continuation of Resource Centers for Minority Aging Research (RCMARs). The primary purpose of this FOA is (1) to support centers that will enhance the diversity of the aging research workforce by mentoring promising scientists from under-represented groups for sustained careers in aging research in a selected area of scientific focus, and (2) to develop infrastructure to promote advances in this area and increase the number of researchers focused on the health and well-being of minority elders. RCMARs focus on priority areas of social, behavioral, and economic research on the processes of aging at the individual or societal level. The program supports research at multiple levels from genetics to cross-national comparative research, and at stages from basic through translational, with the goal to improve the health, well-being, function, and independence of older Americans. This new cycle of RCMARs will expand the scientific scope of the program to encourage transdisciplinary social and behavioral science research on any theme addressed in the National Institute on Aging Strategic Plan. Consistent with the longstanding focus of the RCMAR program on minority aging research, all centers are also expected to offer mentoring in health disparities and minority aging issues as a major component of their research education programs, thereby enhancing the potential impact of research supported by the program on all sectors of our aging society.
Extracellular Vesicles and Substance Use Disorders (R21) - PAR-17-242
Organization: NIDA
Summary: The purpose of this FOA is to encourage research projects that investigate the interplay between extracellular vesicles (EVs) and substance use disorders (SUDs). In particular, NIDA is interested in the potential utility of EVs with respect to understanding neuroplastic mechanisms relevant to SUDs or as biomarkers or therapeutics.
Extracellular Vesicles and Substance Use Disorders (R01) - PAR-17-250
Organization: NIDA
Summary: The purpose of this FOA is to encourage research projects that investigate the interplay between extracellular vesicles (EVs) and substance use disorders (SUDs). In particular, NIDA is interested in the potential utility of EVs with respect to understanding neuroplastic mechanisms relevant to SUDs or as biomarkers or therapeutics.
Limited Competition: Palliative Care Research Cooperative (PCRC) (U2C) - RFA-NR-17-001
Organization: NINR
Summary: The purpose of this Funding Opportunity Announcement (FOA) is to continue support for the research and resource activities of the Palliative Care Research Cooperative (PCRC); and facilitate cutting edge end-of-life and palliative care (EOLPC) research studies that need to be conducted with nationally representative samples and multiple sites.
NIH Notices
Other Funding or Opportunities
None this week |
|
|
|
April 17
|
Evening of Science – 4-6P, Evansdale Crossing
The featured speaker will be Dr. Vinay Badhwar of the Heart and Vascular Institute. |
April 19
|
CCB Spring Seminar Series – 12-1P, HSN Room 2157
Eugenia Broude, PhD
South Carolina College of Pharmacy
University of South Carolina
CDK8/19: a novel transcriptional target for breast cancer therapy
|
April 22
|
Transplant Patient Reunion – 12-2P, Lakeview Resort, Morgantown
|
April 28-30
|
2017 WVU Cancer Institute Spring Gala –
The Greenbrier, White Sulphur Springs, WV
More details
|
|
|
|
|
|
|
